Healthcare Investing

AI Won’t Cure Diseases. This ‘Dull’ Science Will.

The biotech industry is obsessed with AI and high-throughput screening, hoping to find a magic wand for drug discovery. But the real bottleneck isn’t computational power—it’s our embarrassing lack of basic biological understanding. If you want to cure diseases, stop funding the shortcuts and start funding the unglamorous work of disease biology.